XenoGesis’ Global Head of Business Development, Dr Rachel Hemsley has joined the University of Oxford’s Medical Sciences Experts in Residence (ExIR) scheme. The Experts in Residence programme is managed by the Medical Science Division’s Translational Research Office, Business Development & Partnering team and Oxford University Innovation. It aims to give Oxford’s research community access to world-leading...
Inspiration Healthcare and the Ventilator Challenge
See below to find out how Medilink EM Member Company Inspiration Healthcare has played a significant role in the National Ventilator Challenge UK. For more information on Inspiration Healthcare, click here For more information on Medilink EM Membership, click here
Micronclean Donates Coveralls to Care Plus Group
Last Friday morning, Associate Director of Medilink EM Member Company Micronclean, David Parry, donated 6 cartons/130 Coveralls to Care Plus Group (an NHS funded non-for-profit employee-owned organisation responsible for many Adult Health and Social Services in the Northeast Lincolnshire area). Care Plus Group provide a number of services in this area, including the Macmillan...
Help for innovating your way out of the Covid-19 pandemic
Please see below for article from Medilink EM Patron, AdamsonJones on the support which is available to life science SMEs to innovate out of the COVID-19 pandemic There are many organisations offering business support to help UK SMEs through these challenging times. Here, we highlight some key organisations that provide...
How Useful is an NHS Pilot?
Working with innovators in health and care the question of evidence always arises. After all, we work in a world of “evidence-based care” so no one should be spending money on a product for patients where there is no evidence of benefit to the patient, staff, costs or preferably all...
LUNAC Therapeutics selects XenoGesis as strategic drug discovery partner
Nottingham-based leading DMPK provider, XenoGesis, who is a member of the Medicines Discovery Catapult Discovery Services Network, has been selected by LUNAC Therapeutics Limited to support them in the discovery of novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies. LUNAC has been assisted in...
How EU MDR extends compliance responsibility across the supply chain
Beth Crandall, managing director, global solutions delivery leader at Maetrics, outlines the specific changes, how they will affect each entity, and their role in this new regulatory framework. Crandall also warns against the potential outcomes of non-compliance. Since the EU Medical Device Regulation (EU MDR) introduced the concept of “Economic Operators”...
Albumedix Announces Jonas Skjødt Møller As New CEO
Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rAlb), announced today its succession plan as Peter Rosholm, after 13 years leading the company, has decided to step down as CEO and handover the company’s leadership. Peter’ successor as Chief Executive Officer is his long-standing colleague, and the Company’s Chief Operating...
Promethean Particles re-starts production
Medilink EM Member Company Promethean Particles has resumed manufacturing at its site today following the implementation of new safety measures to reduce the risk from Covid-19. The company’s Nottingham site is home to the world’s largest multi-material nanomaterial plant of its kind. In March, it closed its doors in line...
Mental Health Support during the Pandemic
We are currently and will be for some time yet, living and working in strange times which brings new challenges and stress to our daily lives. This is something that most of us will never have experienced in our lifetime. Thankfully times are changing and people are generally opening up...